These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 959709)

  • 1. [The doctor, the pill and lipaemic disorders. Reflections following an investigation (author's transl)].
    Dovy D; Vasseur MC; Balvay M; Bergeron P
    Rev Fr Gynecol Obstet; 1976 Apr; 71(4):289-92. PubMed ID: 959709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
    Akerlund M
    Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Do's and don'ts for a woman who has an abnormal lipid pattern and is taking oral contraceptives].
    Boyet F
    Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1076-7. PubMed ID: 12266510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic risks of oral contraception].
    Monier L
    Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral contraception: failures and risks].
    Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipid metabolism disorders and increased vascular risk due to contraceptive steroids].
    Basdevant A; de Lignieres B; Mauvais-Jarvis P
    Nouv Presse Med; 1976 Apr; 6(17):1469-72. PubMed ID: 1025526
    [No Abstract]   [Full Text] [Related]  

  • 9. [Program of surveillance of patients under oral contraceptives].
    Lefebvre Y
    Union Med Can; 1975 Oct; 104(10):1535-9. PubMed ID: 1220102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. User characteristics and oral contraceptive compliance in Egypt.
    Trottier DA; Potter LS; Taylor BA; Glover LH
    Stud Fam Plann; 1994; 25(5):284-92. PubMed ID: 7871553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [How to choose an oral contraceptive in 1984].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1984 Nov; 12(11):1201-6. PubMed ID: 12266609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral contraception and carbohydrate metabolism: III--practical implications].
    Hilal M
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):59-62. PubMed ID: 12341242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Instructions for combined pill users.
    Reese M; Hatcher RA
    Contracept Technol Update; 1985 Jan; 6(1):19-20. PubMed ID: 12279914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
    Batzer FR
    J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modification of serum lipids and glucose tolerance by sequential Ovosiston and Minisiston].
    Vesper VB; Feustel S
    Zentralbl Gynakol; 1988; 110(4):241-5. PubMed ID: 2453102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraceptive methods and risk factors of cardiovascular diseases in Tehranian women: Tehran Lipid and Glucose Study.
    Azizi F; Ainy E; Mirmiran P; Habibian S
    Eur J Contracept Reprod Health Care; 2002 Mar; 7(1):1-6. PubMed ID: 12041858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The thromboembolic risk of the pill].
    Beaumont JL; Beaumont V; Jan F; Buxtorf JC
    Concours Med; 1976 Dec; 98(44):7057-8, 7061-4, 7067-8. PubMed ID: 991599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pill formulations and their effect on lipid and carbohydrate metabolism.
    Brooks PG
    J Reprod Med; 1984 Jul; 29(7 Suppl):539-46. PubMed ID: 6481707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.